Comparison of four isoxazoline flea and tick products: NexGard, Bravecto, Simparica, and Credelio
View full size
Internal Medicine9 min readDog & Cat

Isoxazoline Flea and Tick Medications: NexGard, Bravecto, Simparica, and Credelio

GABA-gated chloride channel antagonists — kill times, species safety, FDA neurological alert, and cat-approved products

CVPM Hub Veterinary Team
Reviewed by Dr. Susan Little, DVM, PhD, DACVM (Parasitology)
Updated March 11, 2026

Quick Answer

Isoxazoline flea and tick preventatives (afoxolaner, fluralaner, sarolaner, lotilaner) are the most effective antiparasitic drugs available for dogs and select cats. This guide covers mechanism, kill times by species, dosing, FDA 2018 neurological alert, and critical cat safety information.

🏥 Flea and Tick Infestation🩺 Veterinary Parasitology and Preventive Medicine

Key Takeaways

  • Isoxazolines (NexGard, Bravecto, Simparica, Credelio) block GABA-gated chloride channels in arthropods, killing fleas within 8 hours and ticks within 12-48 hours
  • FDA 2018 alert: neurological adverse events (tremors, ataxia, seizures) are real but rare (<0.01%) — do not withhold in healthy animals as tick disease risk is far greater
  • Use with caution in animals with active seizure disorders; discuss risk/benefit with owners of epileptic pets
  • NEVER give dog isoxazoline products to cats — only Bravecto Plus (topical), Credelio Plus, and Revolution Plus are approved for feline use
  • Cat-approved minimum ages: Credelio Plus (8 weeks), Bravecto Plus (6 months) — do not use below minimum age or weight
  • Bravecto provides the longest duration (12 weeks per dose) of any oral flea/tick preventative, improving compliance

GABA Mechanism, Kill Times, and Product Comparison

Isoxazolines are a novel class of insecticides and acaricides that act as potent antagonists of GABA-gated chloride channels (GluCl) in invertebrate nervous systems. This mechanism is highly selective for arthropods over mammals at therapeutic doses.

Mechanism of Action

  • Bind GABA-gated and glutamate-gated chloride channels in arthropod nervous system
  • Sustained channel blockade → uninhibited nerve firing → hyperexcitation
  • Irreversible seizures and death in fleas, ticks, and mites
  • Selectivity for invertebrate vs mammalian channels: 100-fold at therapeutic doses

Kill Times

ParasiteKill Time (after drug exposure)
Fleas (Ctenocephalides felis)8 hours or less
Black-legged tick (Ixodes scapularis)12 hours
American dog tick (Dermacentor variabilis)24 hours
Lone star tick (Amblyomma americanum)24–48 hours
Brown dog tick (Rhipicephalus sanguineus)24–48 hours
Gulf Coast tick24–48 hours
Sarcoptes scabiei (mange mites)Off-label; 2–4 weeks
Demodex canis (off-label)4–8 weeks treatment

Product-by-Product Comparison

ProductActive IngredientDog DoseFrequencyAvailable for Cats
NexGard (Boehringer)Afoxolaner2.5–13.3 mg/kg POMonthlyNo
Bravecto (MSD/Merck)Fluralaner25–56 mg/kg POEvery 12 weeksBravecto Plus (cats, topical)
Simparica (Zoetis)Sarolaner1–3 mg/kg POMonthlySimparica Trio (dogs only)
Credelio (Elanco)Lotilaner20–43 mg/kg POMonthlyCredelio Plus (cats)
Nexgard SpectraAfoxolaner + milbemycinPer weightMonthlyNo
Bravecto Plus (cats)Fluralaner + moxidectin40 mg/kg topicalEvery 8–12 weeksYes — CATS ONLY version
Credelio Plus (cats)Lotilaner + milbemycinPer weightMonthlyYes — CATS ONLY version

Flea Kill Speed Comparison (practical)

  • vs Spinosad (Comfortis): Similar at 4h for fleas
  • vs Nitenpyram (Capstar): Nitenpyram faster onset (30 min) but shorter duration (24h)
  • vs Fipronil (Frontline): Isoxazolines significantly faster on fleas
Isoxazoline product comparison chart showing kill times and dosing for NexGard, Bravecto, Simparica

FDA 2018 Neurological Alert and Risk Management in Seizure-Prone Animals

In September 2018, the FDA issued a drug safety communication alerting veterinarians and owners to neurological adverse events associated with isoxazoline-class products. Understanding this alert is critical for appropriate use.

FDA 2018 Alert Summary The FDA required label updates for all isoxazoline products to include a new Warnings and Precautions section describing neurological adverse events including muscle tremors, ataxia, and seizures.

Reported Adverse Events

EventEstimated IncidenceSeverity
Muscle tremorsRare (<0.01%)Usually mild, self-limiting
Ataxia (incoordination)Rare (<0.01%)Mild, resolves within days
SeizuresVery rare (<0.001%)Potentially serious
Vomiting/diarrhea1–3%Mild, transient
Lethargy1–2%Mild, transient

Who Is at Risk?

  • Dogs/cats with history of epilepsy or seizure disorders
  • Animals on drugs affecting GABAergic neurotransmission (phenobarbital, potassium bromide)
  • Animals with underlying brain disease

Risk Management Protocol

SituationRecommendation
Healthy dog/cat with no seizure historyUse isoxazolines freely — benefit far outweighs risk
Dog/cat with history of single seizure (idiopathic epilepsy)Discuss risk/benefit; many neurologists still recommend isoxazolines as benefits outweigh risk
Active, poorly controlled epilepsyUse alternative product (fluralaner topical for cats; spinosad or topical for dogs)
Currently on phenobarbital/KBrDiscuss with neurologist; isoxazolines can generally still be used with monitoring

Practical Note on Magnitude of Risk Millions of doses administered annually with extremely rare adverse events. The risk of tick-borne diseases (Lyme, anaplasmosis, Rocky Mountain spotted fever, ehrlichiosis) in unprotected dogs in endemic areas vastly outweighs the neurological adverse event risk of isoxazolines. Do not withhold in healthy animals based on label warning alone.

If Adverse Event Occurs 1. Discontinue isoxazoline 2. Initiate symptomatic support (anti-seizure medication if needed) 3. Report to FDA MedWatch and manufacturer 4. Document in medical record and discuss alternative flea/tick products

FDA 2018 isoxazoline neurological alert summary with risk stratification table

Cat-Approved Isoxazolines: Bravecto Plus and Credelio Plus

This section addresses the critical safety distinction between isoxazoline products approved for cats versus those approved for dogs only. This is one of the most important drug safety rules in small animal practice.

CRITICAL SAFETY RULE NEVER use dog isoxazoline products in cats. Dog formulations (NexGard, Bravecto chewable for dogs, Simparica, Credelio for dogs) are dosed for canine body weight and metabolic rate. Giving dog-dose isoxazoline products to cats causes severe toxicity and death.

Cat-Approved Isoxazoline Products

ProductIngredientDoseRouteFrequencyParasites
Bravecto Plus (cats)Fluralaner + moxidectin40 mg/kg fluralanerTopical spot-onEvery 8–12 weeksFleas, ticks, ear mites, roundworms, hookworms
Credelio Plus (cats)Lotilaner + milbemycin6 mg/kg lotilanerPO chewableMonthlyFleas, ticks, roundworms, hookworms
Revolution Plus (cats)Selamectin + sarolanerPer weightTopicalMonthlyFleas, ticks, ear mites, roundworms, hookworms

Bravecto Plus for Cats — Dosing by Weight

Cat WeightVolumeActive Ingredients
1.2–2.8 kg0.4 mL112.5 mg fluralaner + 2.5 mg moxidectin
2.8–6.25 kg0.9 mL250 mg fluralaner + 5 mg moxidectin
6.25–12.5 kg1.8 mL500 mg fluralaner + 10 mg moxidectin

Minimum Age and Weight Requirements

ProductMinimum AgeMinimum Weight
Bravecto Plus (cats)6 months1.2 kg
Credelio Plus (cats)8 weeks0.7 kg
Revolution Plus (cats)8 weeks1.25 kg

Why Cats Are Different

  • Lower hepatic cytochrome P450 activity (reduced drug metabolism)
  • Higher CNS sensitivity to certain insecticides
  • Different body composition affecting drug distribution
  • Grooming behavior that can increase oral exposure to topical products

Environmental Flea Control

  • Treat all pets in household simultaneously
  • Vacuum frequently (stimulates pupae to hatch)
  • Environmental spray with IGR (insect growth regulator — methoprene or pyriproxyfen)
  • All cats in household must be on approved feline product
Cat-approved isoxazoline products Bravecto Plus and Credelio Plus with dosing information

Frequently Asked Questions

How fast do isoxazolines kill fleas?

Isoxazoline products kill fleas within 8 hours of exposure, which is faster than most older products. This rapid kill time is clinically significant for alleviating allergic flea bite dermatitis. The fleas must bite and ingest the drug from the pet's blood before dying.

Are isoxazolines safe for dogs with epilepsy?

The FDA 2018 warning requires caution in animals with seizure history. For dogs with well-controlled epilepsy, most veterinary neurologists still recommend isoxazolines because the risk of tick-borne disease (Lyme, RMSF, anaplasmosis) in unprotected dogs in endemic areas outweighs the very low risk of drug-triggered seizures. Discuss with your neurologist.

Can I use NexGard or Bravecto (dog) on my cat?

No — this is extremely dangerous. Dog isoxazoline formulations are dosed for canine body weight and metabolism. Giving dog flea/tick products to cats causes severe toxicity and can be fatal. Only use Bravecto Plus, Credelio Plus, or Revolution Plus — products specifically formulated and approved for cats.

How long does Bravecto last?

Bravecto (fluralaner) provides flea and tick protection for 12 weeks (3 months) per dose in dogs. Bravecto Plus for cats provides 8-12 weeks of protection. This makes it the longest-acting oral flea/tick preventative available, which improves compliance for owners who forget monthly dosing.

Do isoxazolines kill tick eggs and larvae?

No. Isoxazolines kill adult fleas and ticks that bite the treated animal but do not directly kill eggs or larvae in the environment. For heavy flea infestations, environmental treatment with an insect growth regulator (IGR) and frequent vacuuming is needed alongside treating all pets in the household.

References

  1. FDA Drug Safety Communication: FDA Identifies Potential Neurological Risks with Isoxazoline Flea and Tick Products. September 2018.
  2. Becskei C et al. Efficacy and safety of afoxolaner (NexGard) in dogs. Parasit Vectors. 2016;9(1):1-8.
  3. Meadows C et al. Fluralaner (Bravecto) pharmacokinetics in dogs. Vet Parasitol. 2014;201(1-2):78-84.